Black Diamond Therapeutics, Aterian, and Plug Power are the three Penny stocks to watch today, according to MarketBeat's stock screener tool. Penny stocks are low-priced equity shares, usually trading for less than $5 per share, often issued by small, less-established companies. They tend to be highly volatile and speculative investments, characterized by limited liquidity and minimal regulatory oversight, making them riskier than stocks of larger, well-established companies. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
Black Diamond Therapeutics (BDTX)
Black Diamond Therapeutics, Inc., a clinical-stage oncology medicine company, focuses on the discovery and development of MasterKey therapies for patients with genetically defined tumors. The company's lead product candidate is BDTX-1535, a brain-penetrant epidermal growth factor receptor MasterKey inhibitor, which is in phase 2 clinical trial for the treatment of epidermal growth factor receptor mutant non-small cell lung cancer, as well as phase 1 clinical trial to treat glioblastoma.
NASDAQ:BDTX traded up $0.22 during midday trading on Wednesday, reaching $1.90. The stock had a trading volume of 105,465,613 shares, compared to its average volume of 1,233,143. Black Diamond Therapeutics has a 12-month low of $1.59 and a 12-month high of $7.66. The firm has a fifty day simple moving average of $2.17 and a two-hundred day simple moving average of $2.93. The stock has a market cap of $107.37 million, a P/E ratio of -1.42 and a beta of 2.52.
Read Our Latest Research Report on BDTX
Aterian (ATER)
Aterian, Inc., together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. Its platform offers home and kitchen appliances; kitchenware; cooling and air quality appliances, such as dehumidifiers; health and beauty products; and essential oils under the Squatty Potty, hOmeLabs, Mueller, Pursteam, Healing Solutions, and Photo Paper Direct brand names.
Aterian stock traded up $0.75 during midday trading on Wednesday, reaching $2.86. The company's stock had a trading volume of 49,608,292 shares, compared to its average volume of 296,397. Aterian has a fifty-two week low of $1.86 and a fifty-two week high of $4.32. The stock's 50 day simple moving average is $2.19 and its 200 day simple moving average is $2.56. The firm has a market capitalization of $25.03 million, a PE ratio of -1.05 and a beta of 2.03.
Read Our Latest Research Report on ATER
Plug Power (PLUG)
Plug Power Inc. develops hydrogen and fuel cell product solutions in North America, Europe, Asia, and internationally. The company offers GenDrive, a hydrogen-fueled proton exchange membrane (PEM) fuel cell system that provides power to material handling electric vehicles; GenSure, a stationary fuel cell solution that offers modular PEM fuel cell power to support the backup and grid-support power requirements of the telecommunications, transportation, and utility sectors; ProGen, a fuel cell stack and engine technology used in mobility and stationary fuel cell systems, and as engines in electric delivery vans; GenFuel, a liquid hydrogen fueling delivery, generation, storage, and dispensing system; GenCare, an ongoing Internet of Things-based maintenance and on-site service program for GenDrive fuel cell systems, GenSure fuel cell systems, GenFuel hydrogen storage and dispensing products, and ProGen fuel cell engines; and GenKey, an integrated turn-key solution for transitioning to fuel cell power.
Shares of NASDAQ:PLUG traded down $0.04 during midday trading on Wednesday, hitting $1.59. 82,749,226 shares of the stock were exchanged, compared to its average volume of 47,339,334. The stock has a market cap of $1.47 billion, a P/E ratio of -0.74 and a beta of 1.98. The company has a current ratio of 2.08, a quick ratio of 0.95 and a debt-to-equity ratio of 0.15. Plug Power has a twelve month low of $1.37 and a twelve month high of $4.90. The company has a 50 day moving average price of $1.93 and a 200-day moving average price of $2.08.
Read Our Latest Research Report on PLUG
See Also
Before you consider Black Diamond Therapeutics, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Black Diamond Therapeutics wasn't on the list.
While Black Diamond Therapeutics currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
